Atlas Trials

LMN-201 for Prevention of C. Difficile Infection Recurrence

Clinical trial NCT05330182 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05330182
Sponsor
Lumen Bioscience, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Clostridioides Difficile Infection
Start date
2024-08-29
Primary completion
2026-08-31
Enrollment
375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.